These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 30638931)
1. A Tie2 kinase mutation causing venous malformations increases phosphorylation rates and enhances cooperativity. Kennedy MA; Xu Z; Wu Y; Sohl CD Biochem Biophys Res Commun; 2019 Feb; 509(4):898-902. PubMed ID: 30638931 [TBL] [Abstract][Full Text] [Related]
2. Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression. Hu HT; Huang YH; Chang YA; Lee CK; Jiang MJ; Wu LW J Invest Dermatol; 2008 Sep; 128(9):2325-33. PubMed ID: 18401423 [TBL] [Abstract][Full Text] [Related]
3. STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production. Huang YH; Wu MP; Pan SC; Su WC; Chen YW; Wu LW Angiogenesis; 2013 Jan; 16(1):207-22. PubMed ID: 23086340 [TBL] [Abstract][Full Text] [Related]
4. Transgenic Expression of A Venous Malformation Related Mutation, Du Z; Ma HL; Zhang ZY; Zheng JW; Wang YA Int J Med Sci; 2018; 15(4):385-394. PubMed ID: 29511374 [TBL] [Abstract][Full Text] [Related]
5. Review of the endothelial pathogenic mechanism of TIE2-related venous malformation. Du Z; Zheng J; Zhang Z; Wang Y J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):740-748. PubMed ID: 28818232 [TBL] [Abstract][Full Text] [Related]
6. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Limaye N; Wouters V; Uebelhoer M; Tuominen M; Wirkkala R; Mulliken JB; Eklund L; Boon LM; Vikkula M Nat Genet; 2009 Jan; 41(1):118-24. PubMed ID: 19079259 [TBL] [Abstract][Full Text] [Related]
8. AKT/FOXO1 axis links cross-talking of endothelial cell and pericyte in TIE2-mutated venous malformations. Si Y; Huang J; Li X; Fu Y; Xu R; Du Y; Cheng J; Jiang H Cell Commun Signal; 2020 Aug; 18(1):139. PubMed ID: 32867785 [TBL] [Abstract][Full Text] [Related]
9. Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations. Morris PN; Dunmore BJ; Tadros A; Marchuk DA; Darland DC; D'Amore PA; Brindle NP J Mol Med (Berl); 2005 Jan; 83(1):58-63. PubMed ID: 15526080 [TBL] [Abstract][Full Text] [Related]
10. Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB. Uebelhoer M; Nätynki M; Kangas J; Mendola A; Nguyen HL; Soblet J; Godfraind C; Boon LM; Eklund L; Limaye N; Vikkula M Hum Mol Genet; 2013 Sep; 22(17):3438-48. PubMed ID: 23633549 [TBL] [Abstract][Full Text] [Related]
11. Cutaneomucosal venous malformations are linked to the TIE2 mutation in a large Chinese family. Shu W; Lin Y; Hua R; Luo Y; He N; Fang L; Tan J; Lu J; Hu Z; Yuan Z Exp Dermatol; 2012 Jun; 21(6):456-7. PubMed ID: 22621187 [TBL] [Abstract][Full Text] [Related]
13. Common and specific effects of TIE2 mutations causing venous malformations. Nätynki M; Kangas J; Miinalainen I; Sormunen R; Pietilä R; Soblet J; Boon LM; Vikkula M; Limaye N; Eklund L Hum Mol Genet; 2015 Nov; 24(22):6374-89. PubMed ID: 26319232 [TBL] [Abstract][Full Text] [Related]
14. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. Boscolo E; Limaye N; Huang L; Kang KT; Soblet J; Uebelhoer M; Mendola A; Natynki M; Seront E; Dupont S; Hammer J; Legrand C; Brugnara C; Eklund L; Vikkula M; Bischoff J; Boon LM J Clin Invest; 2015 Sep; 125(9):3491-504. PubMed ID: 26258417 [TBL] [Abstract][Full Text] [Related]
15. A xenograft model for venous malformation. Goines J; Li X; Cai Y; Mobberley-Schuman P; Metcalf M; Fishman SJ; Adams DM; Hammill AM; Boscolo E Angiogenesis; 2018 Nov; 21(4):725-735. PubMed ID: 29786783 [TBL] [Abstract][Full Text] [Related]
16. Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2 Lazovic B; Nguyen HT; Ansarizadeh M; Wigge L; Kohl F; Li S; Carracedo M; Kettunen J; Krimpenfort L; Elgendy R; Richter K; De Silva L; Bilican B; Singh P; Saxena P; Jakobsson L; Hong X; Eklund L; Hicks R Angiogenesis; 2024 Aug; 27(3):523-542. PubMed ID: 38771392 [TBL] [Abstract][Full Text] [Related]
17. Ponatinib Combined With Rapamycin Causes Regression of Murine Venous Malformation. Li X; Cai Y; Goines J; Pastura P; Brichta L; Lane A; Le Cras TD; Boscolo E Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):496-512. PubMed ID: 30626204 [TBL] [Abstract][Full Text] [Related]
18. Classification and Tie2 mutations in spinal and soft tissue vascular anomalies. Zhou M; Jiang R; Zhao G; Wang L; Wang H; Li W; Li Y; Du X; Bai J Gene; 2015 Oct; 571(1):91-6. PubMed ID: 26115772 [TBL] [Abstract][Full Text] [Related]
19. Constitutive Active Mutant TIE2 Induces Enlarged Vascular Lumen Formation with Loss of Apico-basal Polarity and Pericyte Recruitment. Cai Y; Schrenk S; Goines J; Davis GE; Boscolo E Sci Rep; 2019 Aug; 9(1):12352. PubMed ID: 31451744 [TBL] [Abstract][Full Text] [Related]